By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…
By: Miriam Maltz, PharmD Candidate c/o 2013, AMSCOP, Long Island University - Type 2 diabetes mellitus (T2DM) is a metabolic…